This trial will determine the effectiveness and safety of Baricitinib to treat hair loss in children 6-18 years old.
- Alopecia Areata
- Skin Diseases
- Pathological Anatomy
- Hair Loss
1 Primary · 26 Secondary · Reporting Duration: Pre-Vaccination to 4 Weeks and 12 Weeks Post-Vaccination
Side Effects for
Awards & Highlights
3 Treatment Groups
Baricitinib High Dose
1 of 3
Baricitinib Low Dose
1 of 3
1 of 3
595 Total Participants · 3 Treatment Groups
Primary Treatment: Baricitinib High Dose · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 6 - 17 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Do individuals over the age of 35 qualify to participate in this medical research?
"Participants that wish to be part of this trial must fall between 6 and 17 years of age." - Anonymous Online Contributor
How many institutions are overseeing this trial?
"This trial has 4 currently active sites, including Total Skin and Beauty Dermatology Center in Birmingham, Clarkston Skin Research in Clarkston, Texas Dermatology and Laser Specialists in San Antonio. There are also other locations that have been approved to participate." - Anonymous Online Contributor
Has the highest dose of Baricitinib received approval from the Food and Drug Administration?
"Based on the Phase 3 trial results, there is sufficient evidence to assign a score of 3 out of 3 for Baricitinib High Dose's safety profile." - Anonymous Online Contributor
Are there any current opportunities to participate in this clinical experiment?
"The clinical trial data available on clinicaltrials.gov does not indicate that this particular study is actively recruiting patients at the moment; it was first posted on February 28th 2023 and last edited about two weeks later. However, there are currently 128 other trials across various medical areas looking for candidates to participate in their research." - Anonymous Online Contributor
What qualifications are needed for an individual to partake in this clinical trial?
"This research project seeks to enrol 595 alopecia patients, aged 6-17 years old. Eligible participants must have experienced severe AA for more than a year, current hair loss covering 50% of the scalp or higher according to SALT score, failed treatment with topical solutions and/or other treatments previously attempted, participated in psychological counselling related to their condition, and have had an episode of severe AA that has lasted less than 8 years (individuals who have suffered from it for 8+ may still be eligible if regrowth was observed over this period)." - Anonymous Online Contributor